Silexion Therapeutics Corp

Developing a local drug delivery platform to treat KRAS-driven cancers and solid tumors.

SLXN | US

Overview

Corporate Details

ISIN(s):: KYG1281K1141 (+1 more)
LEI:
Country:: United States of America
Address:: 12 ABBA HILLEL ROAD, 5250606 RAMAT GAN
Website:: https://www.moringaac.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Silexion Therapeutics Corp is a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for KRAS-driven cancers and other solid tumors, such as pancreatic cancer. The company's core technology is its proprietary LODER (Local Drug Eluter) drug delivery platform. This platform is designed to provide local and prolonged delivery of therapeutic agents directly within the tumor core, aiming to solve significant drug delivery challenges and improve outcomes for patients with hard-to-treat cancers. Silexion is also developing innovative RNA-based therapeutics and collaborates with industry partners to advance its clinical manufacturing and formulation development.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Silexion Therapeutics Corp filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Silexion Therapeutics Corp

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Silexion Therapeutics Corp via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
GemVax & KAEL Co.,Ltd. Makes contamination controls for semiconductors & develops Alzheimer's therapeutics.	South Korea	082270
Gencurix Inc. Develops molecular diagnostic tests for cancer detection, prognosis, and treatment selection.	South Korea	229000
GENELUX Corp Developing oncolytic viral immunotherapies for difficult-to-treat cancers using a vaccinia virus.	United States of America	GNLX
GENEMATRIX INC. Develops multiplex PCR diagnostics and new drugs for infectious diseases like HPV and tuberculosis.	South Korea	109820
Genenta Science S.p.A. Develops cell & gene therapies using engineered stem cells to treat solid tumors.	United States of America	GNTA
GeneOne Life Science, Inc. Develops nucleic acid vaccines & therapies for infectious diseases, cancer & autoimmune disorders.	South Korea	011000
Generation Bio Co. Developing siRNA genetic medicines via targeted nanoparticles for autoimmune diseases.	United States of America	GBIO
Genetic Analysis AS Develops microbiome diagnostics to detect gut dysbiosis for clinical and pharma partners.	Norway	GEAN
GENFIT Biopharma developing therapies & diagnostics for rare, life-threatening liver diseases.	France	GNFT
Genfit S.A. Biopharma developing therapeutics and diagnostics for rare and life-threatening liver diseases.	United States of America	GNFT